Thank you to our Speakers, Sponsors & Delegates for joining us!
Register your interest to be the first to hear updates about the 2025 meeting.
Streamlining Yield, Quality, Scalability and Compliance of Plasmid and Cell-free DNA Production Platforms to Meet the Increasing Global Demand for High-Quality DNA, RNA, Cell & Gene Therapies
5th-7th March, 2024 | Boston, MA
Welcome to the Inaugural DNA Process Development and Manufacturing Summit
Trailblazing DNA Platforms with Speed & Quality for Better Genetic Medicines
2024 AGENDA
With the cell and gene therapy industry surging, rapid advances in mRNA-based therapies, and the advent of DNA vaccines, the demand for quality DNA as a critical starting and therapeutic material has skyrocketed in recent years.
The Inaugural DNA Process Development and Manufacturing Summit offered a forum dedicated to increasing plasmid and cell-free based DNA production while reducing costs, time, and ensuring regulatory compliance.
Our audience joined us to meet 100+ DNA production experts over 3 days packed with deep-dive workshops, data-led presentations, and dedicated discussion and networking sessions as we addressed the most pressing challenges of producing DNA, brought together by our 18+ expert speakers from leading companies like Sanofi, Roche, Genentech, Pfizer and more.
Top Attending Companies in 2024:
The 2024 Speaker Faculty Included:
"This meeting is an opportunity to learn from experts and have valuable discussions on the critical challenges we face"
Michael Homsy
Senior Scientist, Merck & Co
"This meeting is a valuable opportunity to bring scientists, biopharmaceutical manufacturers, suppliers and regulators together to focus on advancements and opportunities in the field of DNA manufacturing, to seek knowledge exchange and alignment for these important materials. "
Basak Clements
Global Head of Material Science, Pharma
Technology Cell & Gene Therapy, Genentech
Proud to Have Partnered with:
